ALZN · Forms 3, 4, 5
Insider trades at Alzamend Neuro, Inc.
1 insider sold $3K of Alzamend Neuro, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Alzamend Neuro, Inc. (ALZN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Milton C Ault III | Director | Sell | 2,000 | $1.56 | $3K | Form 4 | |
| Hyperscale Data, Inc. | Director | Options or other derivatives | Form 4 | ||||
| Hyperscale Data, Inc. | Director | Became an insider (Form 3) | Form 3 | ||||
| Milton C Ault III | Director | Options or other derivatives | Form 4 | ||||
| Henry Carl Nisser | EVP and General Counsel | Options or other derivatives | Form 5 | ||||
| Milton C Ault III | Director | Options or other derivatives | Form 5 | ||||
| William B. Horne | Director | Options or other derivatives | Form 5 | ||||
| Jeffrey Oram | Director | Options or other derivatives | Form 5 | ||||
| Mark Gustafson | Director | Options or other derivatives | Form 5 | ||||
| Stephan Jackman | Chief Executive Officer | Options or other derivatives | Form 5 | ||||
| David J Katzoff | Chief Financial Officer | Options or other derivatives | Form 5 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.